Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Predictors of treatment response in a web-based intervention for cannabis users.

Jonas B, Tensil MD, Leuschner F, Strüber E, Tossmann P.

Internet Interv. 2019 Jul 26;18:100261. doi: 10.1016/j.invent.2019.100261. eCollection 2019 Dec.

2.

Correction to: Web-Based Intervention and Email‑Counseling for Problem Gamblers: Results of a Randomized Controlled Trial.

Jonas B, Leuschner F, Eiling A, Schoelen C, Soellner R, Tossmann P.

J Gambl Stud. 2019 Nov 27. doi: 10.1007/s10899-019-09914-4. [Epub ahead of print]

PMID:
31773430
3.

How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia.

Jonas BA, Pollyea DA.

Leukemia. 2019 Dec;33(12):2795-2804. doi: 10.1038/s41375-019-0612-8. Epub 2019 Oct 18. Review.

PMID:
31628431
4.

Web-Based Intervention and Email-Counseling for Problem Gamblers: Results of a Randomized Controlled Trial.

Jonas B, Leuschner F, Eiling A, Schoelen C, Soellner R, Tossmann P.

J Gambl Stud. 2019 Nov 27. doi: 10.1007/s10899-019-09883-8. [Epub ahead of print] Erratum in: J Gambl Stud. 2019 Nov 27;:.

PMID:
31560101
5.

Microcannula Injection of Large Gel Particle Hyaluronic Acid for Cheek Augmentation and the Correction of Age-Related Midface Contour Deficiencies.

Jones DH, Hessler J, Chapas A, Jonas B, Crider J, Chopra R.

Dermatol Surg. 2019 Sep 2. doi: 10.1097/DSS.0000000000002105. [Epub ahead of print]

PMID:
31490308
6.

Comparative Effectiveness of Combining MTX with Biologic Drug Therapy Versus Either MTX or Biologics Alone for Early Rheumatoid Arthritis in Adults: a Systematic Review and Network Meta-analysis.

Donahue KE, Schulman ER, Gartlehner G, Jonas BL, Coker-Schwimmer E, Patel SV, Weber RP, Bann CM, Viswanathan M.

J Gen Intern Med. 2019 Oct;34(10):2232-2245. doi: 10.1007/s11606-019-05230-0. Epub 2019 Aug 6.

PMID:
31388915
7.

A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia.

Tomlinson BK, Tuscano JM, Abedi M, Welborn J, Arora M, O'Donnell RT, Wun T, Jonas BA.

Am J Hematol. 2019 Nov;94(11):E291-E294. doi: 10.1002/ajh.25605. Epub 2019 Aug 20. No abstract available.

PMID:
31379016
8.

Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia.

Cortes JE, Jonas BA, Graef T, Luan Y, Stein AS.

Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):509-515.e1. doi: 10.1016/j.clml.2019.05.008. Epub 2019 May 13.

9.

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial.

Cortes JE, Khaled S, Martinelli G, Perl AE, Ganguly S, Russell N, Krämer A, Dombret H, Hogge D, Jonas BA, Leung AY, Mehta P, Montesinos P, Radsak M, Sica S, Arunachalam M, Holmes M, Kobayashi K, Namuyinga R, Ge N, Yver A, Zhang Y, Levis MJ.

Lancet Oncol. 2019 Jul;20(7):984-997. doi: 10.1016/S1470-2045(19)30150-0. Epub 2019 Jun 4. Erratum in: Lancet Oncol. 2019 Jul;20(7):e346.

PMID:
31175001
10.

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy.

Galkin M, Jonas BA.

Core Evid. 2019 Apr 26;14:3-17. doi: 10.2147/CE.S172912. eCollection 2019.

11.

Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science.

Malfatti MA, Buchholz BA, Enright HA, Stewart BJ, Ognibene TJ, McCartt AD, Loots GG, Zimmermann M, Scharadin TM, Cimino GD, Jonas BA, Pan CX, Bench G, Henderson PT, Turteltaub KW.

Toxics. 2019 May 9;7(2). pii: E27. doi: 10.3390/toxics7020027. Review.

12.

Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia.

Lin TY, Zhu Y, Li Y, Zhang H, Ma AH, Long Q, Keck J, Lam KS, Pan CX, Jonas BA.

Nanomedicine. 2019 Aug;20:102004. doi: 10.1016/j.nano.2019.04.007. Epub 2019 May 2.

PMID:
31055076
13.

Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia.

Medeiros BC, Chan SM, Daver NG, Jonas BA, Pollyea DA.

Am J Hematol. 2019 Jul;94(7):803-811. doi: 10.1002/ajh.25484. Epub 2019 May 1. Review.

14.

Clinical Assessment of 2 Licensed AbobotulinumtoxinA Injection Volumes for the Treatment of Glabellar Lines.

Kaufman J, Cohen JL, Peredo MI, Jonas B, Down R, Nogueira A.

Dermatol Surg. 2019 Oct;45(10):1274-1284. doi: 10.1097/DSS.0000000000001926.

PMID:
30893159
15.

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.

DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS, Frankfurt O, Konopleva M, Wei AH, Kantarjian HM, Xu T, Hong WJ, Chyla B, Potluri J, Pollyea DA, Letai A.

Blood. 2019 Jan 3;133(1):7-17. doi: 10.1182/blood-2018-08-868752. Epub 2018 Oct 25.

16.

Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet].

Donahue KE, Gartlehner G, Schulman ER, Jonas B, Coker-Schwimmer E, Patel SV, Weber RP, Lohr KN, Bann C, Viswanathan M.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul.

17.

Toward Predicting Acute Myeloid Leukemia Patient Response to 7 + 3 Induction Chemotherapy via Diagnostic Microdosing.

Scharadin TM, Malfatti MA, Haack K, Turteltaub KW, Pan CX, Henderson PT, Jonas BA.

Chem Res Toxicol. 2018 Oct 15;31(10):1042-1051. doi: 10.1021/acs.chemrestox.8b00107. Epub 2018 Sep 10.

18.

New and emerging therapies for acute myeloid leukaemia.

Davis JR, Benjamin DJ, Jonas BA.

J Investig Med. 2018 Dec;66(8):1088-1095. doi: 10.1136/jim-2018-000807. Epub 2018 Aug 19. Review.

19.

Complications and early mortality in patients with acute promyelocytic leukemia treated in California.

Ho G, Li Q, Brunson A, Jonas BA, Wun T, Keegan THM.

Am J Hematol. 2018 Nov;93(11):E370-E372. doi: 10.1002/ajh.25252. Epub 2018 Sep 26. No abstract available.

20.

Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma.

Rosenberg AS, Brunson A, Jonas BA, Keegan THM, Wun T.

J Natl Cancer Inst. 2019 Jan 1;111(1):78-85. doi: 10.1093/jnci/djy073.

21.

Considering disability and health: Reflections on the Healthy People 2020 Midcourse Review.

Sinclair LB, Fox MH, Jonas BS, Berry HG, Quatrano LA, McGowan AK, Peacock G.

Disabil Health J. 2018 Jul;11(3):333-338. doi: 10.1016/j.dhjo.2018.04.001. Epub 2018 Apr 19.

22.

Effects of Treatment Length and Chat-Based Counseling in a Web-Based Intervention for Cannabis Users: Randomized Factorial Trial.

Jonas B, Tensil MD, Tossmann P, Strüber E.

J Med Internet Res. 2018 May 8;20(5):e166. doi: 10.2196/jmir.9579.

23.

Proteinuria, Hypoalbuminemia, and Chronic Lymphocytic Leukemia: An Unusual Trio.

Wung W, Ananthakrishnan S, Jonas BA.

J Investig Med High Impact Case Rep. 2018 Mar 14;6:2324709618764207. doi: 10.1177/2324709618764207. eCollection 2018 Jan-Dec.

24.

Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.

Ho G, Wun T, Muffly L, Li Q, Brunson A, Rosenberg AS, Jonas BA, Keegan THM.

Cancer. 2018 May 1;124(9):1938-1945. doi: 10.1002/cncr.31296. Epub 2018 Feb 16.

25.

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.

DiNardo CD, Pratz KW, Letai A, Jonas BA, Wei AH, Thirman M, Arellano M, Frattini MG, Kantarjian H, Popovic R, Chyla B, Xu T, Dunbar M, Agarwal SK, Humerickhouse R, Mabry M, Potluri J, Konopleva M, Pollyea DA.

Lancet Oncol. 2018 Feb;19(2):216-228. doi: 10.1016/S1470-2045(18)30010-X. Epub 2018 Jan 12.

PMID:
29339097
26.

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia.

Kjelland JD, Dwyre DM, Jonas BA.

Case Rep Hematol. 2017;2017:3625946. doi: 10.1155/2017/3625946. Epub 2017 Oct 11.

27.

Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance.

Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM, Jonas BA.

Blood Cancer J. 2017 Sep 8;7(9):e605. doi: 10.1038/bcj.2017.81.

28.

Catheter-Associated Urinary Tract Infections: Implementing a Protocol to Decrease Incidence in Oncology Populations
.

McCoy C, Paredes M, Allen S, Blackey J, Nielsen C, Paluzzi A, Jonas B, Radovich P.

Clin J Oncol Nurs. 2017 Aug 1;21(4):460-465. doi: 10.1188/17.CJON.460-465. Review.

PMID:
28738041
29.

On the origin of relapse in AML.

Jonas BA.

Sci Transl Med. 2017 Jul 12;9(398). pii: eaan8205. doi: 10.1126/scitranslmed.aan8205.

30.

Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology.

Swift A, von Grote E, Jonas B, Nogueira A.

Clin Cosmet Investig Dermatol. 2017 Jun 14;10:229-238. doi: 10.2147/CCID.S138155. eCollection 2017.

31.

A new therapeutic target for myelofibrosis is cause for Gli.

Jonas BA.

Sci Transl Med. 2017 May 31;9(392). pii: eaan4297. doi: 10.1126/scitranslmed.aan4297.

32.

Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.

Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM.

Br J Haematol. 2017 Jul;178(1):72-80. doi: 10.1111/bjh.14638. Epub 2017 May 25.

33.

Combination of an oncolytic virus with PD-L1 blockade keeps cancer in check.

Jonas BA.

Sci Transl Med. 2017 Apr 19;9(386). pii: eaan2781. doi: 10.1126/scitranslmed.aan2781.

34.

Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia.

Ho G, Jonas BA, Li Q, Brunson A, Wun T, Keegan THM.

Br J Haematol. 2017 Jun;177(5):791-799. doi: 10.1111/bjh.14631. Epub 2017 Apr 17.

35.

Depressive states among adults with diabetes: Findings from the National Health and Nutrition Examination Survey, 2007-2012.

Albertorio-Diaz JR, Eberhardt MS, Oquendo M, Mesa-Frias M, He Y, Jonas B, Kang K.

Diabetes Res Clin Pract. 2017 May;127:80-88. doi: 10.1016/j.diabres.2017.02.031. Epub 2017 Feb 27.

36.

From MDS/AML to iPSC and back again.

Jonas BA.

Sci Transl Med. 2017 Mar 8;9(380). pii: eaam9861. doi: 10.1126/scitranslmed.aam9861.

37.

KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study.

Swords RT, Greenberg PL, Wei AH, Durrant S, Advani AS, Hertzberg MS, Jonas BA, Lewis ID, Rivera G, Gratzinger D, Fan AC, Felsher DW, Cortes JE, Watts JM, Yarranton GT, Walling JM, Lancet JE.

Leuk Res. 2016 Nov;50:123-131. doi: 10.1016/j.leukres.2016.09.012. Epub 2016 Sep 28. Erratum in: Leuk Res. 2017 Aug;59:65.

PMID:
27736729
38.

Phase sensitive properties and coherent manipulation of a photonic crystal microcavity.

Quiring W, Jonas B, Förstner J, Rai AK, Reuter D, Wieck AD, Zrenner A.

Opt Express. 2016 Sep 5;24(18):20672-84. doi: 10.1364/OE.24.020672.

PMID:
27607671
39.

Efficacy of an internet-based intervention for burnout: a randomized controlled trial in the German working population.

Jonas B, Leuschner F, Tossmann P.

Anxiety Stress Coping. 2017 Mar;30(2):133-144. doi: 10.1080/10615806.2016.1233324. Epub 2016 Sep 22.

PMID:
27602992
41.
42.

Individualizing Therapeutic Strategies in Acute Myeloid Leukemia: Moving Beyond the 'One-Size-Fits-All' Approach.

Jonas BA, Medeiros BC.

Oncology (Williston Park). 2016 Apr;30(4):330, 333. No abstract available.

43.

Translocation (6;15)(q12;q15): A Novel Mutation in a Patient with Therapy-Related Myelodysplastic Syndrome.

Ali SF, Sonu RJ, Dwyre DM, Jonas BA, Rashidi HH.

Case Rep Hematol. 2015;2015:318545. doi: 10.1155/2015/318545. Epub 2015 Dec 21.

44.

Socioeconomic factors and self-reported health outcomes in African Americans with rheumatoid arthritis from the Southeastern United States: the contribution of childhood socioeconomic status.

Baldassari AR, Cleveland RJ, Luong MN, Jonas BL; Consortium for the Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis, Conn DL, Moreland LW, Bridges SL Jr, Callahan LF.

BMC Musculoskelet Disord. 2016 Jan 12;17:10. doi: 10.1186/s12891-016-0882-5.

45.

Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis.

Stelling A, Jonas BA, Rashidi HH, Abedi M, Chen M.

Cancers (Basel). 2015 Dec 14;7(4):2459-65. doi: 10.3390/cancers7040903.

46.

Fellow As Teacher Curriculum: Improving Rheumatology Fellows' Teaching Skills During Inpatient Consultation.

Miloslavsky EM, Criscione-Schreiber LG, Jonas BL, O'rourke KS, McSparron JI, Bolster MB.

Arthritis Care Res (Hoboken). 2016 Jun;68(6):877-81. doi: 10.1002/acr.22733.

47.

B lymphoblastic leukemia with granules mimicking acute myeloid leukemia.

Song JY, Khojeini EV, Dwyre DM, Jonas BA.

Int J Hematol. 2015 Sep;102(3):251-2. doi: 10.1007/s12185-015-1842-9. Epub 2015 Jul 18. No abstract available.

48.

Optimal Molecular Methods in Detecting p190 (BCR-ABL) Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature.

Sonu RJ, Jonas BA, Dwyre DM, Gregg JP, Rashidi HH.

Case Rep Hematol. 2015;2015:458052. doi: 10.1155/2015/458052. Epub 2015 Apr 8.

49.

Paraneoplastic Leukemoid Reaction as a Marker of Tumor Progression in Non-Small Cell Lung Cancer.

McCoach CE, Rogers JG, Dwyre DM, Jonas BA.

Cancer Treat Commun. 2015;4:15-18. No abstract available.

50.

MDS prognostic scoring systems – past, present, and future.

Jonas BA, Greenberg PL.

Best Pract Res Clin Haematol. 2015 Mar;28(1):3-13. doi: 10.1016/j.beha.2014.11.001. Epub 2014 Nov 11. Review.

Supplemental Content

Support Center